1. Home
  2. PRCT vs TMDX Comparison

PRCT vs TMDX Comparison

Compare PRCT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRCT
  • TMDX
  • Stock Information
  • Founded
  • PRCT 2009
  • TMDX 1998
  • Country
  • PRCT United States
  • TMDX United States
  • Employees
  • PRCT N/A
  • TMDX N/A
  • Industry
  • PRCT Medical Specialities
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PRCT Health Care
  • TMDX Health Care
  • Exchange
  • PRCT Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • PRCT 2.9B
  • TMDX 2.3B
  • IPO Year
  • PRCT 2021
  • TMDX 2019
  • Fundamental
  • Price
  • PRCT $53.12
  • TMDX $111.50
  • Analyst Decision
  • PRCT Strong Buy
  • TMDX Buy
  • Analyst Count
  • PRCT 7
  • TMDX 10
  • Target Price
  • PRCT $90.00
  • TMDX $122.89
  • AVG Volume (30 Days)
  • PRCT 1.1M
  • TMDX 1.2M
  • Earning Date
  • PRCT 04-24-2025
  • TMDX 05-08-2025
  • Dividend Yield
  • PRCT N/A
  • TMDX N/A
  • EPS Growth
  • PRCT N/A
  • TMDX N/A
  • EPS
  • PRCT N/A
  • TMDX 1.41
  • Revenue
  • PRCT $249,121,000.00
  • TMDX $488,227,000.00
  • Revenue This Year
  • PRCT $46.28
  • TMDX $25.33
  • Revenue Next Year
  • PRCT $32.67
  • TMDX $20.53
  • P/E Ratio
  • PRCT N/A
  • TMDX $79.36
  • Revenue Growth
  • PRCT 59.36
  • TMDX 64.43
  • 52 Week Low
  • PRCT $47.04
  • TMDX $55.00
  • 52 Week High
  • PRCT $103.81
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • PRCT 46.17
  • TMDX 78.52
  • Support Level
  • PRCT $52.43
  • TMDX $92.49
  • Resistance Level
  • PRCT $56.29
  • TMDX $95.71
  • Average True Range (ATR)
  • PRCT 2.88
  • TMDX 4.79
  • MACD
  • PRCT 0.28
  • TMDX 0.81
  • Stochastic Oscillator
  • PRCT 48.53
  • TMDX 71.36

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: